Therapeutic drug monitoring strategy systematically measures drug concentrations guiding dose individualisation. Optimal sampling times capture peak and trough levels. Target concentration ranges define therapeutic goals. Dose adjustment algorithms personalise therapy. Bioassays quantitate parent drug and active metabolites.
Clinical outcomes correlate with monitored concentrations. Regulatory submissions justify monitoring targets. Post-approval surveillance confirms monitoring utility. Compliance monitoring improves therapeutic outcomes. Emerging point-of-care testing expedites results.
General Biopharmaceutical Concepts
Therapeutic Drug Monitoring Strategy
A therapeutic drug monitoring strategy defines when and how drug concentrations should be measured to optimise efficacy and minimise toxicity.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →